Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iradimed Corp (NQ: IRMD )

49.25 -0.29 (-0.59%)
Streaming Delayed Price Updated: 2:46 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iradimed Corp

< Previous 1 2 3 Next >
iRadimed's Earnings: A Preview
Via Benzinga
Iradimed Notifies Potential Issue With Certain Syringe Adapter Sets During Use
Via Benzinga
iRadimed's Earnings Outlook
Via Benzinga
iRadimed's Return On Capital Employed Insights
Via Benzinga
Recap: iRadimed Q3 Earnings
iRadimed (NASDAQ:IRMD) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings iRadimed beat estimated earnings... 
Via Benzinga
A Preview Of iRadimed's Earnings
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that iRadimed will... 
Via Benzinga
Iradimed Withdraws FDA Application For Updated MR IV Pump System
Via Benzinga
Tesla, Autodesk And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Snowflake Inc. (NYSE: SNOW) surged 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance. 
Via Benzinga
iRadimed: Q1 Earnings Insights
iRadimed (NASDAQ:IRMD) reported its Q1 earnings results on Friday, April 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why iRadimed Shares Are Surging Today?
iRadimed Corporation (NASDAQ: IRMD) reported  
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 127 companies set new 52-week lows. 
Via Benzinga
iRadimed: Q4 Earnings Insights
  iRadimed (NASDAQ:IRMD) reported its Q4 earnings results on Friday, February 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For July 29, 2022
Companies Reporting Before The Bell • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $1.13 per share on revenue of $72.73 million. 
Via Benzinga
Earnings Outlook For iRadimed
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2022-07-29. Here's what investors need to know before the announcement. Analysts estimate that iRadimed will report... 
Via Benzinga
70 Biggest Movers From Friday
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)... 
Via Benzinga
Earnings Preview For iRadimed
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that iRadimed will report... 
Via Benzinga
Earnings Scheduled For April 29, 2022
Companies Reporting Before The Bell • Weyerhaeuser (NYSE:WY) is projected to report quarterly earnings at $1.19 per share on revenue of $2.93 billion. 
Via Benzinga
Cutera Clears Stock Hits Key Benchmark, Hitting 90-Plus RS Rating
Cutera sees its Relative Strength Rating move into the elite 90-plus level. 
Via Investor's Business Daily
7 Safe Stocks to Rely On When the Market Swerves
When markets that have flown so high for so long start to tumble, along with an economy that transitioning, safe stocks are essential. 
Via InvestorPlace
50 Biggest Movers From Friday
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is... 
Via Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Earnings Scheduled For February 4, 2022
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter. 
Via Benzinga
Earnings Outlook For iRadimed
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that iRadimed will likely... 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
7 Excellent Small-Cap Stocks to Buy Before 2022
We've seen big tech rule the markets for a while, but now quality small-cap stocks are likely to begin stealing the headlines. 
Via InvestorPlace
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc... 
Via Benzinga
iRadimed's Earnings Outlook
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2021-10-29. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Earnings Scheduled For October 29, 2021
Companies Reporting Before The Bell • Sify Technologies (NASDAQ:SIFY) is expected to report quarterly earnings at $0.02 per share on revenue of $97.70 million. •... 
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.